Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn - https://www.theguardian.com/business/2026/nov/10/pharma-firms-weight-loss-drugs-insulin-glp-1-ozempic-mounjaro national governments should be producing #insulin themselves